This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Choosing between a Sep Ira and a Simple Ira can be challenging. Discover the key factors to consider for your retirement savings strategy.
15,615 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
As lenders chase ROI from AI, a governance-first pivot for mortgage workflows is gaining steam. Banks report better a...
The White House suspended the Jones Act for 60 days to ease shipping and energy market pressures amid regional confli...
Investors confront a Musk-power dilemma: bet on SpaceX's growth trajectory or Tesla's robotics push. This analysis br...
Oil prices remain a key driver for energy stocks. This article highlights three dividend-friendly picks—Chevron, Exxo...
High-income retirees who wait until age 70 to claim Social Security may face a hidden tax bill, Medicare surcharges, ...
Former official presses lawmakers to reclassify online event markets, arguing they are sports betting. The move inten...
XRP faces a pivotal test as a new AI-driven forecast hints at a multi-dollar rally by the end of 2026, even as the to...
Volatility persists into March 2026, prompting a new, diversified approach to cash flow. A four-ETF plan could target...
A modest sale of 32 BTC by Strategy in late May upended assumptions about corporate Bitcoin buying, pushing investors...
After-hours moves often reveal the next chapter for crypto firms. Gemini shares rise after hours as investors embrace...
A bipartisan Wisconsin panel has found probable cause that Elon Musk’s million offers to voters may violate state ele...